ISSN 1016-5169 | E-ISSN 1308-4488
Archives of the Turkish Society of Cardiology
The trials of novel oral anticoagulants in non-valvular atrial fibrillation and their effect on the guidelines [Turk Kardiyol Dern Ars]
Turk Kardiyol Dern Ars. 2013; 41(4): 7-13

The trials of novel oral anticoagulants in non-valvular atrial fibrillation and their effect on the guidelines

Burçak Kılıçkıran Avcı, Zeki Öngen
Istanbul University Faculty of Medicine, Department of Cardiology, Istanbul, Turkey

Although ischemic stroke is one of the most devastating complications of atrial fibrillation, it can be prevented by effective oral anticoagulation (OAC). Until recently warfarin, a vitamin K antagonist was the only effective OAC in this field. However for the well-known reasons, warfarin is a difficult drug to apply and maintain, both for the patient and physician. In order to overcome these difficulties new oral anticoagulants (NOACs) like, a direct thrombin inhibitor dabigatran and inhibitors of activated factor X rivaroxaban and apixaban are developed as alternatives to warfarin. The efficacy and safety of NOACs vs warfarin, in preventing sroke/TIA and systemic embolism in non-valvular AF is tested in randomized controlled trials (RE-LY, ROCKET AF, ARISTOTLE). Since their efficacy and safety are proven by these trials, the results of the trials had a substantial impact to the writing of new therapy guidelines. Consequently the recent focused update of AF guideline of the ESC suggests NOACs as a strong (even prior to) alternative to warfarin, with the highest level of indication and evidence.


How to cite this article
Burçak Kılıçkıran Avcı, Zeki Öngen. The trials of novel oral anticoagulants in non-valvular atrial fibrillation and their effect on the guidelines. Turk Kardiyol Dern Ars. 2013; 41(4): 7-13

Corresponding Author: Zeki Öngen, Türkiye
Manuscript Language: Turkish


Journal Metrics

Journal Citation Indicator: 0.18
CiteScore: 1.1
Source Normalized Impact
per Paper:
0.22
SCImago Journal Rank: 0.348

Quick Search



Copyright © 2024 Archives of the Turkish Society of Cardiology



Kare Publishing is a subsidiary of Kare Media.